122 related articles for article (PubMed ID: 16762635)
21. Targeting Fanconi anemia/BRCA2 pathway defects in cancer: the significance of preclinical pharmacogenomic models.
Gallmeier E; Kern SE
Clin Cancer Res; 2007 Jan; 13(1):4-10. PubMed ID: 17200332
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
Wreesmann VB; Estilo C; Eisele DW; Singh B; Wang SJ
ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):218-25. PubMed ID: 17409780
[TBL] [Abstract][Full Text] [Related]
23. The genetics of FANCC and FANCG in familial pancreatic cancer.
Rogers CD; van der Heijden MS; Brune K; Yeo CJ; Hruban RH; Kern SE; Goggins M
Cancer Biol Ther; 2004 Feb; 3(2):167-9. PubMed ID: 14726700
[TBL] [Abstract][Full Text] [Related]
24. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice.
Koomen M; Cheng NC; van de Vrugt HJ; Godthelp BC; van der Valk MA; Oostra AB; Zdzienicka MZ; Joenje H; Arwert F
Hum Mol Genet; 2002 Feb; 11(3):273-81. PubMed ID: 11823446
[TBL] [Abstract][Full Text] [Related]
25. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.
Taniguchi T; Tischkowitz M; Ameziane N; Hodgson SV; Mathew CG; Joenje H; Mok SC; D'Andrea AD
Nat Med; 2003 May; 9(5):568-74. PubMed ID: 12692539
[TBL] [Abstract][Full Text] [Related]
26. Characterization of two novel FANCG mutations in Indian Fanconi anemia patients.
Solanki A; Kumar Selvaa C; Sheth F; Radhakrishnan N; Kalra M; Vundinti BR
Leuk Res; 2017 Feb; 53():50-56. PubMed ID: 28024295
[TBL] [Abstract][Full Text] [Related]
27. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
Lensch MW; Tischkowitz M; Christianson TA; Reifsteck CA; Speckhart SA; Jakobs PM; O'Dwyer ME; Olson SB; Le Beau MM; Hodgson SV; Mathew CG; Larson RA; Bagby GC
Blood; 2003 Jul; 102(1):7-16. PubMed ID: 12637330
[TBL] [Abstract][Full Text] [Related]
28. Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia.
Meyer S; Barber LM; White DJ; Will AM; Birch JM; Kohler JA; Ersfeld K; Blom E; Joenje H; Eden TO; Malcolm Taylor G
Br J Haematol; 2006 May; 133(3):284-92. PubMed ID: 16643430
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer.
Pejovic T; Yates JE; Liu HY; Hays LE; Akkari Y; Torimaru Y; Keeble W; Rathbun RK; Rodgers WH; Bale AE; Ameziane N; Zwaan CM; Errami A; Thuillier P; Cappuccini F; Olson SB; Cain JM; Bagby GC
Cancer Res; 2006 Sep; 66(18):9017-25. PubMed ID: 16982743
[TBL] [Abstract][Full Text] [Related]
30. Clinical, cytogenetic and molecular findings in nine Moroccan patients with Fanconi anemia.
Doubaj Y; Zrhidri A; Elalaoui SC; Lyahyai J; El Kadiri Y; Elkassimi N; Sbiti A; El Kababri M; Hessissen L; Sefiani A
Pan Afr Med J; 2021; 39():72. PubMed ID: 34422195
[TBL] [Abstract][Full Text] [Related]
31. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.
Yamamoto K; Ishiai M; Matsushita N; Arakawa H; Lamerdin JE; Buerstedde JM; Tanimoto M; Harada M; Thompson LH; Takata M
Mol Cell Biol; 2003 Aug; 23(15):5421-30. PubMed ID: 12861027
[TBL] [Abstract][Full Text] [Related]
32. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair.
Matsushita N; Kitao H; Ishiai M; Nagashima N; Hirano S; Okawa K; Ohta T; Yu DS; McHugh PJ; Hickson ID; Venkitaraman AR; Kurumizaka H; Takata M
Mol Cell; 2005 Sep; 19(6):841-7. PubMed ID: 16168378
[TBL] [Abstract][Full Text] [Related]
33. Fanconi anemia gene mutations in young-onset pancreatic cancer.
van der Heijden MS; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 2003 May; 63(10):2585-8. PubMed ID: 12750283
[TBL] [Abstract][Full Text] [Related]
34. Young patients with oral squamous cell carcinoma: study of the involvement of GSTP1 and deregulation of the Fanconi anemia genes.
Tremblay S; Pintor Dos Reis P; Bradley G; Galloni NN; Perez-Ordonez B; Freeman J; Brown D; Gilbert R; Gullane P; Irish J; Kamel-Reid S
Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):958-66. PubMed ID: 16982972
[TBL] [Abstract][Full Text] [Related]
35. Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H
Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555
[TBL] [Abstract][Full Text] [Related]
36. Impaired removal of DNA interstrand cross-link in Nijmegen breakage syndrome and Fanconi anemia, but not in BRCA-defective group.
Tsuchida K; Komatsu K
Cancer Sci; 2008 Nov; 99(11):2238-43. PubMed ID: 18771529
[TBL] [Abstract][Full Text] [Related]
37. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway.
Qiao F; Mi J; Wilson JB; Zhi G; Bucheimer NR; Jones NJ; Kupfer GM
J Biol Chem; 2004 Oct; 279(44):46035-45. PubMed ID: 15299017
[TBL] [Abstract][Full Text] [Related]
39. Novel inactivating mutations of FANCC in Brazilian patients with Fanconi anemia.
Yates J; Keeble W; Pals G; Ameziane N; van Spaendonk R; Olson S; Akkari Y; Pasquini R; Bagby G
Hum Mutat; 2006 Feb; 27(2):214. PubMed ID: 16429406
[TBL] [Abstract][Full Text] [Related]
40. A case report of Fanconi anemia diagnosed by genetic testing followed by prenatal diagnosis.
Lee HJ; Park S; Kang HJ; Jun JK; Lee JA; Lee DS; Park SS; Seong MW
Ann Lab Med; 2012 Sep; 32(5):380-4. PubMed ID: 22950077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
